Continuous exposure to isoprenaline reduced myotube size by delaying myoblast differentiation and fusion through the NFAT-MEF2C signaling pathway.

MLA

Yue, Jing, et al. “Continuous Exposure to Isoprenaline Reduced Myotube Size by Delaying Myoblast Differentiation and Fusion through the NFAT-MEF2C Signaling Pathway.” Scientific Reports, vol. 12, no. 1, Jan. 2023, pp. 1–17. EBSCOhost, https://doi.org/10.1038/s41598-022-22330-w.

APA

Yue, J., Xu, W., Xiang, L., Chen, S., Li, X., Yang, Q., Zhang, R., Bao, X., Wang, Y., Mbadhi, M., Liu, Y., Yao, L., Chen, L., Zhao, X., Hu, C., Zhang, J., Zheng, H., Wu, Y., Chen, S.-Y., & Li, S. (2023). Continuous exposure to isoprenaline reduced myotube size by delaying myoblast differentiation and fusion through the NFAT-MEF2C signaling pathway. Scientific Reports, 12(1), 1–17. https://doi.org/10.1038/s41598-022-22330-w

Chicago

Yue, Jing, Wei Xu, Li Xiang, Shao-juan Chen, Xin-yuan Li, Qian Yang, Ruo-nan Zhang, et al. 2023. “Continuous Exposure to Isoprenaline Reduced Myotube Size by Delaying Myoblast Differentiation and Fusion through the NFAT-MEF2C Signaling Pathway.” Scientific Reports 12 (1): 1–17. doi:10.1038/s41598-022-22330-w.